LSU Health tumor registry data find acadiana colon cancer rates among nation's highest
2014-10-10
(Press-News.org) New Orleans, LA – A special study using data from LSU Health New Orleans School of Public Health's Louisiana Tumor Registry has found that colorectal cancer incidence rates in the Louisiana Acadian parishes are among the highest in the United States. This study appears to be the first to identify a high rate of cancer in a large, regional, US founder population, raising the possibility of a genetic predisposition. Alternatively, an unidentified, robust environmental risk factor may be present. The paper is published online in Clinical and Translational Gastroenterology, a Nature journal, at http://www.nature.com/ctg/journal/v5/n10/full/ctg201410a.html.
The study was led by Dr. Jordan Karlitz, Division of Gastroenterology at Tulane University School of Medicine who is also adjunct faculty at the LSU Health New Orleans School of Public Health, Dr. Xiao-Cheng Wu, Professor of Public Health and Director of the LSU Health New Orleans Louisiana Tumor Registry, Dr. Vivien Chen, LSU Health Professor of Public Health, and Dr. Elizabeth Fontham, Professor and Founding Dean Emeritus of the LSU Health New Orleans School of Public Health.
The research team chose to study the Acadian parishes where French is spoken as these parishes are home to the Cajun population that migrated to the region in the 1700s from Canada and France. The Cajuns are a founder population – a new population founded by a small number of individuals who have limited genetic variation relative to the larger original population. Founder populations are important to study as diseases with a hereditary basis, such as certain genetic conditions and cancers, can be seen with increased frequency. Results can yield important information about cancer susceptibility genes not only for the population being studied, but for others worldwide who may share a similar heritage.
The research team identified 18 Acadian parishes and stratified 2005-2009 cancer incidence data by age, ethnicity and gender by utilizing French language census data. A total of 3,288 colorectal cancer cases were identified in the Acadian region and 11,737 in Louisiana. They identified a subgroup of 9 parishes with higher proportions of French speakers, a marker for the Cajun population. Colorectal cancer rates in whites and white males in the 18 parishes were statistically significantly higher than both Louisiana and US rates. In the 9 parishes, rates increased further; whites had an incidence of 56.1 per 100,000, 13% higher than Louisiana and 23% higher than the US rate. In white males, incidence was 72.6 per 100,000, 19% higher than Louisiana and 37% higher than the US rate. If the 9-parish region were considered a "state," white males would have the highest colorectal cancer incidence in the United States by 11% compared with other white male populations.
"This study has identified disproportionately high rates of colorectal cancer in the Acadian parishes of Louisiana," says Dr. Karlitz. "The research highlights the importance of utilizing data made available by high-quality population-based cancer registries to identify at-risk populations that can have important implications with regard to health care delivery. Future studies to assess genetic and environmental risk factors will be necessary to better understand the colorectal cancer incidence in this population."
"This study demonstrates the importance of the Louisiana Tumor Registry at the LSU Health New Orleans School of Public Health in identifying areas and populations at high risk of cancer. Without the population-based state registry, we would not have such data for cancer control and research," notes Dr. Wu.
Concludes senior author Dr. Elizabeth Fontham, who is from the region, "This study has provided provocative findings of a potential link between high colorectal cancer risk and the Acadian population of south Louisiana. Additional studies in this population are important in order to better understand the roles of specific factors, both genetic and/or environmental."
INFORMATION:
The research team also included registry liaison Patricia Andrews, MPH, Instructor of Epidemiology at LSU Health New Orleans School of Public Health, and Dr. Christine Blanton, Division of Gastroenterology at the Tulane University School of Medicine.
This study was supported by National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) grant # HHSN2612013000161 to LSU Health New Orleans and Centers for Disease Control and Prevention National Program of Cancer Registries grant # 5U58DP003915 to LSU Health New Orleans.
The National Cancer Institute designated LSU Health New Orleans' Louisiana Tumor Registry as a SEER registry in 2001. It is one of 18 registries in the United States comprising the Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute. The SEER Program is the only comprehensive source of population-based information in the United States that includes stage of cancer at the time of diagnosis and patient survival data. The SEER Program is considered the standard for quality among cancer registries around the world.
LSU Health Sciences Center New Orleans educates Louisiana's health care professionals. The state's health university leader, LSU Health New Orleans includes a School of Medicine, the state's only School of Dentistry, Louisiana's only public School of Public Health, and Schools of Allied Health Professions, Nursing, and Graduate Studies. LSU Health New Orleans faculty take care of patients in public and private hospitals and clinics throughout the region. In the vanguard of biosciences research in a number of areas in a worldwide arena, the LSU Health New Orleans research enterprise generates jobs and enormous economic impact. LSU Health New Orleans faculty have made lifesaving discoveries and continue to work to prevent, advance treatment, or cure disease. To learn more, visit http://www.lsuhsc.edu, http://www.twitter.com/LSUHSCHealth or http://www.facebook.com/LSUHSC.
ELSE PRESS RELEASES FROM THIS DATE:
An enzyme and synaptic plasticity
2014-10-10
A small, "empty" space teeming with activity: a synapse is a complex structure where the neural (electrical) signal from the presynaptic neuron, as it travels towards its target –a muscle, a gland or another neuron – turns into a chemical signal capable of crossing the synaptic space before becoming electrical again once on the other side. A synapse is a "dynamic" space not only because of the endless work that goes on there, but also for its ability to change its action over time (synaptic plasticity) as a result of either normal physiological processes (e.g., ...
The Lancet Global Health: Widely used sanitation programs do not necessarily improve health
2014-10-10
The sanitation intervention delivered under the terms of the Government of India's Total Sanitation Campaign—the world's largest sanitation initiative—provided almost 25 000 individuals in rural India with access to a latrine. However, it did not reduce exposure to faecal pathogens or decrease the occurrence of diarrhoea, parasitic worm infections, or child malnutrition.
"The programme is effective in building latrines, but not all households participate"*, explains lead author Professor Thomas Clasen from Emory University, Atlanta, USA and the London School ...
University of Maryland School of Medicine begins Ebola vaccine trials in Mali
2014-10-10
VIDEO:
Dr. Myron M. Levine, Director of the Center for Vaccine Development at the University of Maryland School of Medicine describes the Ebola vaccine testing taking place in Mali, West Africa.
Click here for more information.
Professor Myron M. Levine, MD, Director of the Center for Vaccine Development (CVD) at the University of Maryland School of Medicine (UM SOM), and UM SOM Dean E. Albert Reece MD, PhD, MBA, announced today that the CVD, in conjunction with its sister institution, ...
TSRI scientists create mimic of 'good' cholesterol to fight heart disease and stroke
2014-10-10
LA JOLLA, CA – October 9, 2013 - Scientists at The Scripps Research Institute (TSRI) have created a synthetic molecule that mimics "good" cholesterol and have shown it can reduce plaque buildup in the arteries of animal models. The molecule, taken orally, improved cholesterol in just two weeks.
This research, published in the October issue of Journal of Lipid Research, points scientists toward a new method for treating atherosclerosis, a condition where plaque buildup in the arteries can cause heart attacks and strokes.
"Atherosclerosis is the number one killer ...
Fish moving poleward at rate of 26 kilometers per decade
2014-10-10
Large numbers of fish will disappear from the tropics by 2050, finds a new University of Britsh Columbia study that examined the impact of climate change on fish stocks. The study identified ocean hotspots for local fish extinction but also found that changing temperatures will drive more fish into the Arctic and Antarctic waters.
Using the same climate change scenarios as the Intergovernmental Panel on Climate Change, researchers projected a large-scale shift of marine fish and invertebrates. In the worst-case scenario, where the Earth's oceans warm by three degrees ...
Using a novel biological aging clock, UCLA researchers find obesity accelerates aging of the liver
2014-10-10
Using a recently developed biomarker of aging known as an epigenetic clock, UCLA researchers working closely with a German team of investigators have found for the first time that obesity greatly accelerates aging of the liver. This finding could explain the early onset of many age-related diseases, including liver cancer, in obese subjects
Although it had long been suspected that obesity ages a person faster, it hadn't been possible to prove the theory, said study first author Steve Horvath, a professor of human genetics at the David Geffen School of Medicine at UCLA ...
New meningitis vaccine only cost-effective at low price
2014-10-10
The ideal cost per dose for a new meningitis vaccine ranges from £3 up to a possible £22 only if several vaccine favourable factors all coincide, according to research which has analysed how to maximise the reduction in cases while making a new vaccination programme cost-effective.
Bexsero is the first vaccine to broadly protect against meningitis B disease, but research now suggests the Government would need to negotiate a considerable reduction in the £75 list price in order to provide the same value for money as other programmes in the NHS.
In March ...
CNIO researchers associate 2 oncogenes with the agressiveness and incidence of leukaemia in mice
2014-10-10
Proteins regulating cell division determine tumour growth. Ongoing clinical trials are currently studying inhibitors for two of these proteins, Cdk4 and Cdk6, targeting several types of cancer, such as breast cancer, lung cancer and leukaemia. The Cell Division and Cancer Group at the Spanish National Cancer Research Centre (CNIO), led by Marcos Malumbres, has discovered the molecular mechanism behind the interaction of these proteins. Researchers also demonstrated in mice that the simultaneous inhibition of both molecules is more effective than the individual inhibition. ...
Leaky galaxies lead researchers to better understand the universe
2014-10-10
Focusing on large, star-forming galaxies, researchers at the Johns Hopkins University were able to measure radiation leaks in an effort to better understand how the universe evolved as the first stars were formed.
Sanchayeeta Borthakur, an assistant research scientist in the Department of Physics and Astronomy in the university's Krieger School of Arts and Sciences, reports in a paper published online Oct. 9 in the journal Science that an indicator used for studying star-forming galaxies that leak radiation is an effective measurement tool for other scientists to use. ...
Hormone loss could be involved in colon cancer
2014-10-10
(PHILADELPHIA) – Some cancers, like breast and prostate cancer, are driven by hormones such as estrogen and testosterone, but to date, there are none that are driven by the lack of a hormone. New evidence suggests that human colon cells may become cancerous when they lose the ability to produce a hormone that helps the cells maintain normal biology. If verified by further studies, it suggests that treating patients at high risk for colon cancer by replacing the hormone guanylin could prevent the development of cancer.
The researchers at Thomas Jefferson University ...